HY21 result: API (ASX:API) share price falls
The Australian Pharmaceutical Industries Ltd (ASX:API) share price is down over 2% after reporting its FY21 half-year result.
Changes are happening - please bear with us while we update our site. Click here to give us your advice and feedback.
The Australian Pharmaceutical Industries Ltd (ASX:API) share price is down over 2% after reporting its FY21 half-year result.
The Latitude Financial Services Limited (ASX:LFS) share price is finally going to hit the stock boards with its ASX IPO. The LFS IPO has been on since 2019, when Latitude wanted to IPO.
The Australian Pharmaceutical Industries Ltd (ASX:API) share price is down over 2% after reporting its FY21 half-year result.
The Latitude Financial Services Limited (ASX:LFS) share price is finally going to hit the stock boards with its ASX IPO. The LFS IPO has been on since 2019, when Latitude wanted to IPO.
Want to level-up your analytical skills and investing insights but don’t know where to start? We can help. Join 40,000+ Australian investors on our mailing list today and we’ll send you our favourite podcasts, courses, resources, investment articles and podcasts every week. Delivered to your inbox every Sunday morning. Grab a coffee and let Owen and the team bring you the best investment insights every week.